REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Icn Polfa Rzeszow S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Secondary Activities: Other Food Manufacturing | Soap, Cleaning Compound, and Toilet Preparation Manufacturing | Other Activities Related to Credit Intermediation | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences | Management of Companies and Enterprises | Packaging and Labeling Services
Full name: Icn Polfa Rzeszow S.A. Profile Updated: December 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

ICN Polfa Rzeszów S.A. is a part of an international consortium Valeant Pharmaceuticals International. It is one of the leading manufacturers of medical products in Poland. It runs also commercial activity within the scope of medicines turnover and service manufacturing. The company consists of Medicines Factory in Rzeszow which has a status of corporate Global Manufacturing Place as well as Czech, Slovakian, and Hungarian organizations Valeant Pharmaceuticals, Int. and their assets. The office in Warsaw coordinates the activities and manages the company's business.

Headquarters
Ul. Przemyslowa 2
Rzeszow; Podkarpackie; Postal Code: 35-959

Contact Details: Purchase the Icn Polfa Rzeszow S.A. report to view the information.

Website: http://www.icnpolfa.pl/

Basic Information
Total Employees:
Purchase the Icn Polfa Rzeszow S.A. report to view the information.
Outstanding Shares:
Purchase the Icn Polfa Rzeszow S.A. report to view the information.
Registered Capital:
Purchase the Icn Polfa Rzeszow S.A. report to view the information.
Financial Auditors:
Purchase the Icn Polfa Rzeszow S.A. report to view the information.
Incorporation Date:
January 24, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Cadogan Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Icn Polfa Rzeszow S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
19.54%▲
Total operating revenue
19.76%▲
Operating profit (EBIT)
20.01%▲
EBITDA
12.23%▲
Net Profit (Loss) for the Period
N/A
Total assets
-3.16%▼
Total equity
-2.89%▼
Operating Profit Margin (ROS)
0.03%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.01%▲
Quick Ratio
6.87%▲
Cash Ratio
3.85%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
Lek S.A.
Bayer Sp. z o.o.
 
"Roche Polska" Sp. z o.o.
Teva Operations Poland Sp. z o.o.
 
Adamed Pharma S.A.
Celon S.A.
 
Biotee Polska Sp. z o.o.
Phytopharm Kleka S.A.
 
Bioton S.A.
Przedsiebiorstwo Farmaceutyczne Jelfa S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo